Calder Biosciences Inc.

Farmingdale, NY

UEI
YZYMDHZG3ZN7
CAGE
83Q49
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3 Bioscience Park Dr rm 511, Farmingdale, NY 11735, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
An RSV prefusion f vaccine that overcomes immunosenescence R44AG064107 National Institute on Aging (NIH) $6,175,781
An adjuvant for an RSV prefusion f vaccine that safely protects infants via maternal vaccination R43AI140941 National Institute of Allergy and Infectious Diseases (NIH) $599,742
Dityrosine locked prefusion f protein: a path to a protective RSV vaccine R44AI112124 National Institute of Allergy and Infectious Diseases (NIH) $1,499,167

Quick answers

Is Calder Biosciences Inc. registered in SAM.gov?

Yes. Calder Biosciences Inc.'s SAM.gov registration is active through May 3, 2027.

What is Calder Biosciences Inc.'s most recent federal award?

Calder Biosciences Inc.'s most recent federal grant award is An RSV prefusion f vaccine that overcomes immunosenescence (R44AG064107), from National Institute on Aging (NIH), on May 15, 2019.

On GovTribe

See Calder Biosciences Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login